Cargando…
Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer
Aspirin's potential as a drug continues to be evaluated for the prevention of colorectal cancer (CRC). Although multiple targets for aspirin and its metabolite, salicylic acid, have been identified, no unifying mechanism has been proposed to clearly explain its chemopreventive effects. Our goal...
Autores principales: | Dachineni, Rakesh, Kumar, D. Ramesh, Callegari, Eduardo, Kesharwani, Siddharth S., Sankaranarayanan, Ranjini, Seefeldt, Teresa, Tummala, Hemachand, Bhat, G. Jayarama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673027/ https://www.ncbi.nlm.nih.gov/pubmed/29075787 http://dx.doi.org/10.3892/ijo.2017.4167 |
Ejemplares similares
-
The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2019) -
Aspirin metabolites 2,3-DHBA and 2,5-DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2020) -
In Vitro and In Vivo Antimetastatic Effect of Glutathione Disulfide Liposomes
por: Sadhu, Satya S, et al.
Publicado: (2017) -
Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?—The Metabolite Hypothesis
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2020) -
Aspirin inhibits glucose-6-phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites
por: Ai, Guoqiang, et al.
Publicado: (2016)